Furthermore, IOE (0.2 mg/mL) has similar efficacy to 10 μM of MyD88 inhibitor (NBP2–29328) in recovering the LPS-mediated abnormal expression of inflammatory mediators in C6 glioma cells. The gene discussed is MYD88; the disease is central nervous system cancer.